Characteristics of Adult Patients With Melanoma Diagnosis <40 Years Age.
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Melanoma of Skin. Basic parameters: 18 years — 39 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Italy
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Demographic, Clinical, Dermoscopic, Phenotypic and Genetic Characteristics of Adult Patients With Melanoma Diagnosis <40 Years Age. A Prospective, Monocentric Observational Study
Overview
The primary objective of the study is to analyse a local cohort of patients aged 18-39 years with melanoma diagnosis in order to determine the prevalence of the disease in this age group. Secondary objectives are the following: * To identify risk factors associated with melanoma in young people. * To characterise the phenotype and dermoscopic features of melanoma in patients aged 18-39 years. * To analyse the relationship between the clinical and histopathological features of melanoma in young people. * To identify the mutational status of B-RAF in the sample of patients analysed.
Primary outcome measures
- Melanoma prevalence [Time frame: 3 years]
Secondary outcome measures (5)
- Risk factor [Time frame: 3 years]
- Melanoma phenotype [Time frame: 3 years]
- Histopathological feature [Time frame: 3 years]
- Mutational status [Time frame: 3 years]
- Dermoscopy of melanoma [Time frame: 3 years]
Eligibility criteria
Inclusion criteria
- written informed consent
- age > 18 years and < 40 years
- diagnosis of cutaneous melanoma even non-primary
Exclusion criteria
\-
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Italy · 1 center
- E.O. Ospedali Galliera — Genoa
Identifiers
NCT: NCT06994208 · Melanoma_2025